We are live on ! Find out more
JUNO

Juno Therapeutics, Inc.
JUNO

Delisted

JUNO was delisted on the 5th of March, 2018.

Back to rankings

101 hedge funds and large institutions have $2.39B invested in Juno Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 101 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
+101
Holders Change %
–
% of All Funds
2.69%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.11%
New
101
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$234M
2
Capital World Investors
Capital World Investors
California
+$108M
3
VM
VHCP Management
New York
+$78.3M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$51.5M
5
Temasek Holdings
Temasek Holdings
Singapore
+$41M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Brown Advisory
26
Brown Advisory
Maryland
$5.12M +$4.38M +97,944 New
UBS AM
27
UBS AM
Illinois
$5.09M +$4.36M +97,400 New
UBS Group
28
UBS Group
Switzerland
$5.04M +$4.32M +96,612 New
FCMI
29
Foresite Capital Management II
California
$4.78M +$4.1M +91,575 New
FAM
30
Fred Alger Management
New York
$4.27M +$3.66M +81,698 New
Lazard Asset Management
31
Lazard Asset Management
New York
$4.24M +$3.64M +81,260 New
DFO
32
Duquesne Family Office
New York
$3.65M +$3.13M +70,000 New
Vanguard Group
33
Vanguard Group
Pennsylvania
$3.65M +$3.13M +70,000 New
Marshall Wace
34
Marshall Wace
United Kingdom
$3.26M +$2.8M +62,514 New
WRF
35
Waddell & Reed Financial
Kansas
$3.26M +$2.79M +62,400 New
Tudor Investment Corp
36
Tudor Investment Corp
Connecticut
$3.17M +$2.71M +60,631 New
Citadel Advisors
37
Citadel Advisors
Florida
$2.65M +$2.28M +50,837 New
DekaBank Deutsche Girozentrale
38
DekaBank Deutsche Girozentrale
Germany
$2.64M +$2.18M +48,700 New
LCM
39
Laurion Capital Management
New York
$2.61M +$2.24M +50,000 New
OA
40
Omega Advisors
New York
$2.61M +$2.24M +50,000 New
OTPPB
41
Ontario Teachers' Pension Plan Board
Ontario, Canada
$2.61M +$2.24M +50,000 New
O
42
OppenheimerFunds
New York
$2.61M +$2.24M +50,000 New
PA
43
Perceptive Advisors
New York
$2.61M +$2.24M +50,000 New
GGHC
44
Gilder Gagnon Howe & Co
New York
$2.59M +$2.22M +49,557 New
ACPU
45
Arrowgrass Capital Partners (US)
Delaware
$2.44M +$2.09M +46,791 New
JP Morgan Chase
46
JP Morgan Chase
New York
$2.3M +$1.97M +43,962 New
VAM
47
Visium Asset Management
New York
$2.12M +$1.81M +40,523 New
WMSA
48
Weiss Multi-Strategy Advisers
New York
$2.09M +$1.79M +40,000 New
PIM
49
Platinum Investment Management
Australia
$2.09M +$1.79M +40,000 New
BG
50
BlackRock Group
United Kingdom
$1.94M +$1.66M +37,086 New
1
2
3 4 5

JUNO Hedge Fund Activity: Q4 2014 in Review

101 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Juno Therapeutics, Inc. (JUNO) for Q4 2014, worth a combined $2.39B.

Buyers outnumbered sellers: 101 funds opened new JUNO positions and 0 closed out — a net gain of 101 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $234M.

  • 101 institutional investors held Juno Therapeutics, Inc. (JUNO) as of Q4 2014, up from 0 in Q3 2014.
  • Funds reported $2.39B of Juno Therapeutics, Inc. stock for Q4 2014.
  • 101 funds opened new Juno Therapeutics, Inc. positions in Q4 2014 and 0 closed out, a net change of +101 holders.
  • The largest Juno Therapeutics, Inc. buyer in Q4 2014 was Fidelity Investments, an estimated $234M added.

Based on aggregated 13F filings for Q4 2014.